Therapeutic apheresis in ANCA Associated Vasculitis: Current status of Pexivas

^*Corresponding author for this work

Original language	English
Article number	103683
Journal	Transfusion and Apheresis Science
Volume	62
Issue number	2
ISSN	1473-0502
DOIs	https://doi.org/10.1016/j.transci.2023.103683
Publication status	Published - Apr 2023

Keywords

@article{159bb4e332c84bdfa20a4cf11f4f2334,

title = "Therapeutic apheresis in ANCA Associated Vasculitis: Current status of Pexivas",

keywords = "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/therapy, Blood Component Removal, Humans",

author = "Szpirt, {Wladimir M}",

year = "2023",

month = apr,

doi = "10.1016/j.transci.2023.103683",

language = "English",

volume = "62",

journal = "Transfusion and Apheresis Science",

issn = "1473-0502",

publisher = "Pergamon",

number = "2",

}

TY - JOUR

T1 - Therapeutic apheresis in ANCA Associated Vasculitis

T2 - Current status of Pexivas

AU - Szpirt, Wladimir M

PY - 2023/4

Y1 - 2023/4

KW - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/therapy

KW - Blood Component Removal

KW - Humans

UR - http://www.scopus.com/inward/record.url?scp=85149667889&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2023.103683

DO - 10.1016/j.transci.2023.103683

M3 - Review

C2 - 36870912

SN - 1473-0502

VL - 62

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

IS - 2

M1 - 103683

ER -